News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
637,097 Results
Type
Article (32431)
Company Profile (693)
Press Release (603973)
Section
Business (196493)
Career Advice (2123)
Deals (36066)
Drug Delivery (97)
Drug Development (77347)
Employer Resources (161)
FDA (15101)
Job Trends (14620)
News (330952)
Policy (28747)
Tag
Academia (1302)
Alliances (46523)
Alzheimer's disease (1190)
Approvals (15054)
Artificial intelligence (139)
Bankruptcy (365)
Best Places to Work (10842)
Biotechnology (475)
Breast cancer (163)
Cancer (1268)
Cardiovascular disease (100)
Career advice (1750)
Cell therapy (285)
Clinical research (62340)
Collaboration (488)
Compensation (264)
COVID-19 (2153)
C-suite (120)
Data (1336)
Diabetes (163)
Diagnostics (6130)
Earnings (81188)
Employer resources (139)
Events (107060)
Executive appointments (409)
FDA (15743)
Funding (427)
Gene therapy (189)
GLP-1 (604)
Government (2901)
Healthcare (16005)
Infectious disease (2242)
Inflammatory bowel disease (111)
Interviews (422)
IPO (17032)
Job creations (4205)
Job search strategy (1457)
Layoffs (481)
Legal (7121)
Lung cancer (185)
Manufacturing (222)
Medical device (13350)
Medtech (13355)
Mergers & acquisitions (19212)
Metabolic disorders (450)
Neuroscience (1524)
NextGen Class of 2024 (5990)
Non-profit (2065)
Northern California (1719)
Obesity (259)
Opinion (226)
Patents (122)
People (55922)
Pharmaceutical (141)
Phase I (19618)
Phase II (27875)
Phase III (20624)
Pipeline (516)
Postmarket research (1911)
Preclinical (7875)
Radiopharmaceuticals (250)
Rare diseases (261)
Real estate (5706)
Regulatory (20056)
Research institute (1320)
Resumes & cover letters (335)
Southern California (1453)
Startups (3858)
United States (15369)
Vaccines (544)
Weight loss (190)
Date
Today (66)
Last 7 days (160)
Last 30 days (1870)
Last 365 days (35201)
2025 (72)
2024 (35577)
2023 (40264)
2022 (50448)
2021 (53657)
2020 (50727)
2019 (42165)
2018 (32209)
2017 (32384)
2016 (30646)
2015 (36058)
2014 (28701)
2013 (23601)
2012 (25172)
2011 (25363)
2010 (23245)
Location
Africa (669)
Arizona (128)
Asia (39352)
Australia (6419)
California (3949)
Canada (1461)
China (320)
Colorado (173)
Connecticut (187)
Europe (85552)
Florida (506)
Georgia (133)
Illinois (327)
Indiana (235)
Maryland (541)
Massachusetts (3138)
Michigan (187)
Minnesota (301)
New Jersey (1126)
New York (1090)
North Carolina (828)
Northern California (1719)
Ohio (133)
Pennsylvania (916)
South America (1060)
Southern California (1453)
Texas (569)
Utah (108)
Washington State (419)
637,097 Results for "ert parent company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kraig Biocraft Laboratories Nears Completion of Largest Production Batch of Parental Line Spider Silk Silkworms
October 14, 2024
·
3 min read
Press Releases
Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem
October 8, 2024
·
7 min read
Press Releases
Kraig Biocraft Laboratories Leverages New Production Center for Largest Ever Batch of Spider Silk Parental Lines
October 1, 2024
·
3 min read
BioCapital
Duchenne UK and Parent Project Muscular Dystrophy Award $500,000 to Evaluate Safety and Tolerability of Muscle Progenitor Cells in Phase 1 Trial
Parent Project Muscular Dystrophy (PPMD), a US nonprofit organization, and the UK charity Duchenne UK, two leading organizations dedicated to ending Duchenne muscular dystrophy (Duchenne), are excited to announce the recipient of their Joint Call for Therapeutic Projects.
April 23, 2024
·
5 min read
News
Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation
September 17, 2024
·
3 min read
Policy
Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models
Ikerian AG (“Ikerian”) a leader in developing software solutions for medical image and data management and artificial intelligence (AI) in healthcare, today announced the registration as Class IIa medical devices under the European Union Medical Device Regulation (Regulation (EU) 2017/745) (EU-MDR) of 4 devices.
June 24, 2024
·
3 min read
Business
Immunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the Board
Therapeutic Solutions International, Inc. (TSOI) Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distribution of its Shares to Shareholders of Parent Company.
May 9, 2024
·
4 min read
Satellos Announces Presentation at Parent Project Muscular Dystrophy (PPMD) 30th Annual Conference
Satellos Bioscience Inc. today announced that Frank Gleeson, Satellos CEO, will join leading members of the Duchenne medical and scientific community during a panel discussion at PPMD’s 30th Annual Conference being held from June 27–29, 2024 in Orlando, Florida.
June 27, 2024
·
7 min read
Government
Trump to Appoint Celebrity Physician Dr. Oz to Head CMS
The selection of controversial TV personality Mehmet Oz to run the agency overseeing Medicare and Medicaid follows Trump’s pick of RFK Jr. to run its parent department, HHS.
November 20, 2024
·
2 min read
·
Tristan Manalac
Biotech Beach
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Review Latest Developments of CAP-1002 Program
Capricor Therapeutics announced that the Company will host a webinar with the nonprofit organization Parent Project Muscular Dystrophy to review key regulatory details and provide clinical updates that support the advancement of its ongoing HOPE-3, Phase 3 clinical trial of CAP-1002 for treating Duchenne muscular dystrophy.
October 19, 2023
·
4 min read
1 of 63,710
Next
